$1,000 invested Eli Lilly and Company (2016)
NYSE · LLY · reinvest dividends · adjusted close
●Result2016-01-04 — 2026-10-15
Today you would have
$17,961
+$16,961 (+1,696.13%)
LLYSPY (benchmark)
- Entry price
- $69.68
- Current price
- $1251.61
- Shares
- 14.3506
- CAGR
- +30.73%
- Max Drawdown
- -34.48%
- vs SPY
- +1341.89 pp
✦The story
A $1,000 investment in Eli Lilly in early 2016 grew to $17,961 by mid-2026, a total return of +1,696.1%. What began as a steady pharmaceutical holding was transformed by the success of the company's diabetes and weight-loss drug franchise in the 2020s. Over the same decade the S&P 500 returned +354.2%.
#Related scenariosfor comparison
Other years for LLY